Aptuit | Target validation

Target Validation

Picking the right one

Aptuit's complete package of methodologies, whether performed as individual experimental studies, custom-tailored or as a fully-integrated set of biological/safety or PK studies, are key to delivering a robust validation of the biological target at an early stage.

Target validation for early drug discovery

Our multi-disciplinary approach includes studies based on biological or pharmacological tools, and/or the distribution of the target. We can also carry out substantiation of the initial hypothesis via an in vivo approach, whether through disease-relevant animal models or the most advanced gene manipulation techniques.

You can take advantage of our areas of expertise in target validation for early drug discovery to support standalone or integrated drug discovery projects.

Read our article on over reliance on computational PAINS filters by Serge Parel